Sun Pharma has offered to pay $14 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top ...
Sun Pharmaceutical Industries will buy ​U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion ...
Sun alleges that World Liberty Financial froze the digital tokens he had purchased, locking him out of assets worth as much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results